A new development of triterpene acid-containing extracts from Viscum album L. displays synergistic induction of apoptosis in acute lymphoblastic leukaemia

Cell Proliferation

Volumn 45, Issue 2, 2012, Pages 176-187

  Delebinski, C I ^a   Jaeger, S ^b,c   Kemnitz Hassanin, K ^a   Henze, G ^a   Lode, H N ^d   Seifert, G J ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Birken AG   (Germany)

^c Betulin Institute   (Germany)

^d UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILEUKEMIC AGENT; CASPASE 8; CASPASE 9; CYCLODEXTRIN; LIPOCORTIN 5; TRITERPENE DERIVATIVE; VISCUM ALBUM EXTRACT; VISCUM ALBUM LECTIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG SCREENING; DRUG SYNTHESIS; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; POST TREATMENT SURVIVAL; SOLUBILIZATION; SURVIVAL TIME; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CASPASE 3; CASPASE 8; CASPASE 9; CELL LINE, TUMOR; CELL PROLIFERATION; CYTOCHROMES C; DRUG SYNERGISM; FEMALE; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICE, SCID; OLEANOLIC ACID; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LECTINS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SOLUBILITY; TRITERPENES; VISCUM ALBUM; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS; VISCUM; VISCUM ALBUM;

EID: 84857624883     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2011.00801.x     Document Type: Article

References (69)

1. Lenartz D, Dott U, Menzel J, Schierholz JM, Beuth J (2000) Survival of glioma patients after complementary treatment with galactoside-specific lectin from mistletoe. Anticancer Res.20, 2073-2076.
2. Duong Van Huyen JP, Delignat S, Bayry J, Kazatchkine MD, Bruneval P, Nicoletti Aet al. (2006) Interleukin-12 is associated with the in vivo anti-tumor effect of mistletoe extracts in B16 mouse melanoma. Cancer Lett.243, 32-37.
3. Hajto T (1986) Immunomodulatory effects of iscador: a Viscum album preparation. Oncology43(Suppl. 1), 51-65.
4. Thies A, Dautel P, Meyer A, Pfuller U, Schumacher U (2008) Low-dose mistletoe lectin-I reduces melanoma growth and spread in a SCID mouse xenograft model. Br. J. Cancer98, 106-112.
5. Elluru SR, Van Huyen JP, Delignat S, Kazatchkine MD, Friboulet A, Kaveri SVet al. (2008) Induction of maturation and activation of human dendritic cells: a mechanism underlying the beneficial effect of Viscum album as complimentary therapy in cancer. BMC Cancer8, 161.
6. Huber R, Rostock M, Goedl R, Ludtke R, Urech K, Buck Set al. (2005) Mistletoe treatment induces GM-CSF- and IL-5 production by PBMC and increases blood granulocyte- and eosinophil counts: a placebo controlled randomized study in healthy subjects. Eur. J. Med. Res.10, 411-418.
7. Park JH, Hyun CK, Shin HK (1999) Cytotoxic effects of the components in heat-treated mistletoe (Viscum album). Cancer Lett.139, 207-213.
8. Bussing A, Azhari T, Ostendorp H, Lehnert A, Schweizer K (1994) Viscum album L. extracts reduce sister chromatid exchanges in cultured peripheral blood mononuclear cells. Eur. J. Cancer30A, 1836-1841.
9. Ribereau-Gayon G, Jung ML, Baudino S, Salle G, Beck JP (1986) Effects of mistletoe (Viscum album L.) extracts on cultured tumor cells. Experientia42, 594-599.
10. Bussing A (2000) Biological and pharmacological properties of Viscum album L. Mistletoe-The Genus Viscum, p. 123-182. Amsterdam: Harwood Academic Publishers.
11. Schaller G, Urech K, Grazi G, Giannattasio M (1998) Viscotoxin composition of the three European subspecies of Viscum album. Planta Med.64, 677-678.
12. Urech K, Schaller G, Jaggy C (2006) Viscotoxins, mistletoe lectins and their isoforms in mistletoe (Viscum album L.) extracts Iscador. Arzneimittelforschung56, 428-434.
13. Elsasser-Beile U, Voss M, Schuhle R, Wetterauer U (2000) Biological effects of natural and recombinant mistletoe lectin and an aqueous mistletoe extract on human monocytes and lymphocytes in vitro. J. Clin. Lab. Anal.14, 255-259.
14. Elsasser-Beile U, Lusebrink S, Grussenmeyer T, Wetterauer U, Schultze-Seemann W (1998) Comparison of the effects of various clinically applied mistletoe preparations on peripheral blood leukocytes. Arzneimittelforschung48, 1185-1189.
15. Gabius HJ, Andre S, Kaltner H, Siebert HC, von der Lieth CW, Gabius S (1996) The mistletoe myth - claims, reality and provable perspectives. Z. Arztl. Fortbild. (Jena)90, 103-110.
16. Franz H (1986) Mistletoe lectins and their A and B chains. Oncology43(Suppl. 1), 23-34.
17. Franz H, Ziska P, Kindt A (1981) Isolation and properties of three lectins from mistletoe (Viscum album L.). Biochem. J.195, 481-484.
18. Valentiner U, Pfuller U, Baum C, Schumacher U (2002) The cytotoxic effect of mistletoe lectins I, II and III on sensitive and multidrug resistant human colon cancer cell lines in vitro. Toxicology171, 187-199.
19. Hajto T, Hostanska K, Berki T, Palinkas L, Boldizsar F, Nemeth P (2005) Oncopharmacological perspectives of a Plant Lectin (Viscum album Agglutinin-I): overview of recent results from in vitro experiments and in vivo animal models, and their possible relevance for clinical applications. Evid. Based. Complement Alternat. Med.2, 59-67.
20. Jung ML, Baudino S, Ribereau-Gayon G, Beck JP (1990) Characterization of cytotoxic proteins from mistletoe (Viscum album L.). Cancer Lett.51, 103-108.
21. Bussing A, Vervecken W, Wagner M, Wagner B, Pfuller U, Schietzel M (1999) Expression of mitochondrial Apo2.7 molecules and caspase-3 activation in human lymphocytes treated with the ribosome-inhibiting mistletoe lectins and the cell membrane permeabilizing viscotoxins. Cytometry37, 133-139.
22. Bussing A, Suzart K, Bergmann J, Pfuller U, Schietzel M, Schweizer K (1996) Induction of apoptosis in human lymphocytes treated with Viscum album L. is mediated by the mistletoe lectins. Cancer Lett.99, 59-72.
23. Lyu SY, Park WB, Choi KH, Kim WH (2001) Involvement of caspase-3 in apoptosis induced by Viscum album var. coloratum agglutinin in HL-60 cells. Biosci. Biotechnol. Biochem.65, 534-541.
24. Bantel H, Engels IH, Voelter W, Schulze-Osthoff K, Wesselborg S (1999) Mistletoe lectin activates caspase-8/FLICE independently of death receptor signaling and enhances anticancer drug-induced apoptosis. Cancer Res.59, 2083-2090.
25. Seifert G, Jesse P, Laengler A, Reindl T, Luth M, Lobitz Set al. (2008) Molecular mechanisms of mistletoe plant extract-induced apoptosis in acute lymphoblastic leukemia in vivo and in vitro. Cancer Lett.264, 218-228.
26. Fulda S, Jeremias I, Steiner HH, Pietsch T, Debatin KM (1999) Betulinic acid: a new cytotoxic agent against malignant brain-tumor cells. Int. J. Cancer82, 435-441.
27. Laszczyk MN (2009) Pentacyclic triterpenes of the lupane, oleanane and ursane group as tools in cancer therapy. Planta Med.75, 1549-1560.
28. Jager S, Winkler K, Pfuller U, Scheffler A (2007) Solubility studies of oleanolic acid and betulinic acid in aqueous solutions and plant extracts of Viscum album L. Planta Med.73, 157-162.
29. Ovesna Z, Vachalkova A, Horvathova K, Tothova D (2004) Pentacyclic triterpenoic acids: new chemoprotective compounds. Minireview. Neoplasma51, 327-333.
30. Huang MT, Ho CT, Wang ZY, Ferraro T, Lou YR, Stauber Ket al. (1994) Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid. Cancer Res.54, 701-708.
31. Safayhi H, Sailer ER (1997) Anti-inflammatory actions of pentacyclic triterpenes. Planta Med.63, 487-493.
32. Fulda S, Debatin KM (2000) Betulinic acid induces apoptosis through a direct effect on mitochondria in neuroectodermal tumors. Med. Pediatr. Oncol.35, 616-618.
33. Wollenweber E, Wieland A, Haas K (2000) Epicuticular waxes and flavonol aglycones of the European mistletoe, Viscum album L. Z. Naturforsch. C.55, 314-317.
34. Assefa H, Nimrod A, Walker L, Sindelar R (1999) Synthesis and evaluation of potential complement inhibitory semisynthetic analogs of oleanolic acid. Bioorg. Med. Chem. Lett.9, 1889-1894.
35. Deeb D, Gao X, Jiang H, Dulchavsky SA, Gautam SC (2009) Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells by independently targeting pro-survival Akt and mTOR. Prostate69, 851-860.
36. Deeb D, Gao X, Jiang H, Janic B, Arbab AS, Rojanasakul Yet al. (2010) Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells through a ROS-dependent mechanism. Biochem. Pharmacol.79, 350-360.
37. Gao X, Deeb D, Jiang H, Liu Y, Dulchavsky SA, Gautam SC (2007) Synthetic triterpenoids inhibit growth and induce apoptosis in human glioblastoma and neuroblastoma cells through inhibition of prosurvival Akt, NF-kappaB and Notch1 signaling. J. Neurooncol.84, 147-157.
38. Urech K, Scher JM, Hostanska K, Becker H (2005) Apoptosis inducing activity of viscin, a lipophilic extract from Viscum album L. J. Pharm. Pharmacol.57, 101-109.
39. Li R, Quan P, Liu DF, Wei FD, Zhang Q, Xu QW (2009) The influence of cosolvent on the complexation of HP-beta-cyclodextrins with oleanolic acid and ursolic acid. AAPS PharmSciTech.10, 1137-1144.
40. Guo M, Zhang S, Song F, Wang D, Liu Z, Liu S (2003) Studies on the non-covalent complexes between oleanolic acid and cyclodextrins using electrospray ionization tandem mass spectrometry. J. Mass Spectrom.38, 723-731.
41. Jager S, Trojan H, Kopp T, Laszczyk MN, Scheffler A (2009) Pentacyclic triterpene distribution in various plants - rich sources for a new group of multi-potent plant extracts. Molecules14, 2016-2031.
42. Manojlovic V, Winkler K, Bunjes V, Neub A, Schubert R, Bugarski Bet al. (2008) Membrane interactions of ternary phospholipid/cholesterol bilayers and encapsulation efficiencies of a RIP II protein. Colloids Surf. B Biointerfaces64, 284-296.
43. Jager S, Beffert M, Hoppe K, Nadberezny D, Frank B, Scheffler A (2011) Preparation of herbal tea as infusion or by maceration at room temperature using mistletoe tea as an example. Scientia Pharmaceutica79, 145-155.
44. Cho SH, Chung KS, Choi JH, Kim DH, Lee KT (2009) Compound K, a metabolite of ginseng saponin, induces apoptosis via caspase-8-dependent pathway in HL-60 human leukemia cells. BMC Cancer9, 449.
45. Gassmann M, Grenacher B, Rohde B, Vogel J (2009) Quantifying Western blots: pitfalls of densitometry. Electrophoresis30, 1845-1855.
46. Kim MS, So HS, Lee KM, Park JS, Lee JH, Moon SKet al. (2000) Activation of caspase cascades in Korean mistletoe (Viscum album var. coloratum) lectin-II-induced apoptosis of human myeloleukemic U937 cells. Gen. Pharmacol.34, 349-355.
47. Webb RJ (1963) Effect of more than one inhibitor. In: Enzyme and Metabolic Inhibitors, Vol. 1, 66-79, 488-512. New York: Academic Press.
48. Jesse P, Mottke G, Eberle J, Seifert G, Henze G, Prokop A (2009) Apoptosis-inducing activity of Helleborus niger in ALL and AML. Pediatr. Blood Cancer52, 464-469.
49. Duong Van Huyen JP, Delignat S, Kazatchkine MD, Kaveri SV (2003) Comparative study of the sensitivity of lymphoblastoid and transformed monocytic cell lines to the cytotoxic effects of Viscum album extracts of different origin. Chemotherapy49, 298-302.
50. Kim MS, Lee J, Lee KM, Yang SH, Choi S, Chung SYet al. (2003) Involvement of hydrogen peroxide in mistletoe lectin-II-induced apoptosis of myeloleukemic U937 cells. Life Sci.73, 1231-1243.
51. Zuco V, Supino R, Righetti SC, Cleris L, Marchesi E, Gambacorti-Passerini Cet al. (2002) Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells. Cancer Lett.175, 17-25.
52. Ehrhardt H, Fulda S, Fuhrer M, Debatin KM, Jeremias I (2004) Betulinic acid-induced apoptosis in leukemia cells. Leukemia18, 1406-1412.
53. Fulda S, Scaffidi C, Susin SA, Krammer PH, Kroemer G, Peter MEet al. (1998) Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid. J. Biol. Chem.273, 33942-33948.
54. Hengartner MO (2000) The biochemistry of apoptosis. Nature407, 770-776.
55. Zou W, Liu X, Yue P, Zhou Z, Sporn MB, Lotan Ret al. (2004) c-Jun NH2-terminal kinase-mediated up-regulation of death receptor 5 contributes to induction of apoptosis by the novel synthetic triterpenoid methyl-2-cyano-3, 12-dioxooleana-1, 9-dien-28-oate in human lung cancer cells. Cancer Res.64, 7570-7578.
56. Petronelli A, Saulle E, Pasquini L, Petrucci E, Mariani G, Biffoni Met al. (2009) High sensitivity of ovarian cancer cells to the synthetic triterpenoid CDDO-Imidazolide. Cancer Lett.282, 214-228.
57. Zou W, Chen S, Liu X, Yue P, Sporn MB, Khuri FRet al. (2007) c-FLIP downregulation contributes to apoptosis induction by the novel synthetic triterpenoid methyl-2-cyano-3, 12-dioxooleana-1, 9-dien-28-oate (CDDO-Me) in human lung cancer cells. Cancer Biol. Ther.6, 1614-1620.
58. Yue P, Zhou Z, Khuri FR, Sun SY (2006) Depletion of intracellular glutathione contributes to JNK-mediated death receptor 5 upregulation and apoptosis induction by the novel synthetic triterpenoid methyl-2-cyano-3, 12-dioxooleana-1, 9-dien-28-oate (CDDO-Me). Cancer Biol. Ther.5, 492-497.
59. Zhang P, Li H, Chen D, Ni J, Kang Y, Wang S (2007) Oleanolic acid induces apoptosis in human leukemia cells through caspase activation and poly(ADP-ribose) polymerase cleavage. Acta Biochim. Biophys. Sin. (Shanghai)39, 803-809.
60. Ikeda T, Nakata Y, Kimura F, Sato K, Anderson K, Motoyoshi Ket al. (2004) Induction of redox imbalance and apoptosis in multiple myeloma cells by the novel triterpenoid 2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid. Mol. Cancer Ther.3, 39-45.
61. Konopleva M, Tsao T, Estrov Z, Lee RM, Wang RY, Jackson CEet al. (2004) The synthetic triterpenoid 2-cyano-3, 12-dioxooleana-1, 9-dien-28-oic acid induces caspase-dependent and -independent apoptosis in acute myelogenous leukemia. Cancer Res.64, 7927-7935.
62. Vene R, Larghero P, Arena G, Sporn MB, Albini A, Tosetti F (2008) Glycogen synthase kinase 3beta regulates cell death induced by synthetic triterpenoids. Cancer Res.68, 6987-6996.
63. Samudio I, Kurinna S, Ruvolo P, Korchin B, Kantarjian H, Beran Met al. (2008) Inhibition of mitochondrial metabolism by methyl-2-cyano-3, 12-dioxooleana-1, 9-diene-28-oate induces apoptotic or autophagic cell death in chronic myeloid leukemia cells. Mol. Cancer Ther.7, 1130-1139.
64. Frantz M, Jung ML, Ribereau-Gayon G, Anton R (2000) Modulation of mistletoe (Viscum album L.) lectins cytotoxicity by carbohydrates and serum glycoproteins. Arzneimittelforschung50, 471-478.
65. Ribereau-Gayon G, Jung ML, Frantz M, Anton R (1997) Modulation of cytotoxicity and enhancement of cytokine release induced by Viscum album L. extracts or mistletoe lectins. Anticancer Drugs8(Suppl. 1), S3-S8.
66. Place AE, Suh N, Williams CR, Risingsong R, Honda T, Honda Yet al. (2003) The novel synthetic triterpenoid, CDDO-imidazolide, inhibits inflammatory response and tumor growth in vivo. Clin. Cancer Res.9, 2798-2806.
67. Liby K, Risingsong R, Royce DB, Williams CR, Ma T, Yore MMet al. (2009) Triterpenoids CDDO-methyl ester or CDDO-ethyl amide and rexinoids LG100268 or NRX194204 for prevention and treatment of lung cancer in mice. Cancer Prev. Res. (Phila)2, 1050-1058.
68. Yamai H, Sawada N, Yoshida T, Seike J, Takizawa H, Kenzaki Ket al. (2009) Triterpenes augment the inhibitory effects of anticancer drugs on growth of human esophageal carcinoma cells in vitro and suppress experimental metastasis in vivo. Int. J. Cancer125, 952-960.
69. Hua Y, Zhang Z, Li J, Li Q, Hu S, Li Jet al. (2009) Oleanolic acid derivative Dex-OA has potent anti-tumor and anti-metastatic activity on osteosarcoma cells in vitro and in vivo. Invest. New Drugs29, 258-265.